Roles > EC 6.1.1.11 (serine--tRNA ligase) inhibitor

Page last updated: 2024-08-05 15:38:40

EC 6.1.1.11 (serine--tRNA ligase) inhibitor

An EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor that specifically inhibits the action of seryl-tRNA synthetase (EC 6.1.1.11).

ChEBI ID: 75495

Members (1)

Member	Definition	Class
serine hydroxamate	A hydroxamic acid obtained by formal condensation of the carboxy group of serine with the amino group of hydroxylamine.	serine hydroxamate

Research

Studies (39)

Timeframe	Studies, Drugs with This Role(%)	All Drugs %
pre-1990	4 (10.26)	18.7374
1990's	11 (28.21)	18.2507
2000's	16 (41.03)	29.6817
2010's	8 (20.51)	24.3611
2020's	0 (0.00)	2.80

Study Types

Publication Type	Studies, Drugs with this Role (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	40 (100.00%)	84.16%

Protein Targets (0)